GALAPAGOS NV's ticker is GLPG and the CUSIP is 36315X101. A total of 38 filers reported holding GALAPAGOS NV in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,185,000 | -10.6% | 17,200 | 0.0% | 0.01% | -12.5% |
Q1 2021 | $1,326,000 | +59.6% | 17,200 | +104.8% | 0.01% | +33.3% |
Q4 2020 | $831,000 | -30.3% | 8,400 | 0.0% | 0.01% | -33.3% |
Q3 2020 | $1,192,000 | -11.2% | 8,400 | +23.5% | 0.01% | -18.2% |
Q2 2020 | $1,342,000 | +229.7% | 6,800 | -32.0% | 0.01% | +37.5% |
Q3 2015 | $407,000 | – | 10,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 250,680 | $13,188,000 | 7.26% |
Stonepine Capital Management, LLC | 244,205 | $12,848,000 | 5.85% |
Sio Capital Management, LLC | 224,719 | $11,822,000 | 3.77% |
EcoR1 Capital, LLC | 1,558,749 | $82,006,000 | 2.85% |
BVF INC/IL | 1,119,733 | $58,909,000 | 2.30% |
683 Capital Management, LLC | 701,421 | $36,902,000 | 1.44% |
DAFNA Capital Management LLC | 77,675 | $4,086,000 | 1.08% |
Soleus Capital Management, L.P. | 115,300 | $6,066,000 | 0.94% |
APOGEM CAPITAL LLC | 19,267 | $1,014,000 | 0.64% |
Orbimed Advisors | 723,457 | $38,061,000 | 0.42% |